1263774-38-4

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1263774-30-6 [benzyl-(2-chloropropyl)-amino]acetic acid tert-butyl ester 
• 1263774-31-7 1-benzyl-3-methylazetidine-2-carboxylic acid tert-butyl ester 
• 1263774-32-8 3-methylazetidine-1,2-dicarboxylic acid di-tert-butyl ester 
• 1263774-33-9 3-methyl-2-(3-methyl-but-2-enyl)-azetidine-1,2-dicarboxylic acid di-tert-butyl ester 
• 1263774-37-3 6-benzyl-3-methyl-1,6-diazaspiro[3.4]octan-5-one 
• 1263774-35-1 2-(2-benzylaminoethyl)-3-methylazetidine-1,2-dicarboxylic acid di-tert-butyl ester 
• 1263774-34-0 3-methyl-2-(2-oxoethyl)azetidine-1,2-dicarboxylic acid di-tert-butyl ester 

Downstream Products

• 1263774-39-5 3-methyl-1,6-diazaspiro[3.4]octane-1-carboxylic acid tert-butyl ester 
• 1263772-79-7 3-(3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile 

Relevant academic research and scientific papers

NITROGEN-CONTAINING SPIROCYCLIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF

A compound of the following general formula [I]: wherein each symbol has the same meaning as defined herein, or a pharmaceutically acceptable salt thereof, or a solvate thereof, and a pharmaceutical use of the same in treating organ transplant rejection, graft versus host reaction after transplantation, autoimmune disease, allergic disease and chronic myeloproliferative disease.